Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Archives of Virology|September 5, 2002
Identification of human astrovirus infections from stool samples with diarrhea in KoreaY-H Kang, Y-K Park, J-B Ahn, et al.
ESMO Open|September 26, 2022
The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regressionC M Kim, J B Lee, S J Shin, et al.
British Journal of Cancer|July 27, 2007
A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance statusH-C Jeung, S Y Rha, S J Shin, et al.
British Journal of Cancer|November 16, 2006
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimensH-C Jeung, S Y Rha, B C Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancerJ Jeong, H-C Jeung, S Y Rha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2008
Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patientsH Chang, S Y Rha, H-C Jeung, et al.
Cancer Letters|May 23, 2001
Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancerJ B Ahn, K Y Shim, H C Jeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastasesS H Cheon, S Y Rha, H-C Jeung, et al.
American Journal of Clinical Oncology|February 24, 2001
Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancerJ B Ahn, W K Ko, J G Lee, et al.
International Journal of Molecular Medicine|December 19, 1998
Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancerH C Chung, S Y Rha, J B Ahn, et al.
Pageof 2